Literature DB >> 8791717

The Koch phenomenon and the immunopathology of tuberculosis.

G A Rook1, J L Stanford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8791717     DOI： 10.1007/978-3-642-80166-2_11

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  11 in total

1.  Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection.

Authors:  U Seitzer; K Kayser; H Höhn; P Entzian; H H Wacker; S Ploetz; H D Flad; J Gerdes; M J Maeurer
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

2.  Skin test performed with highly purified Mycobacterium tuberculosis recombinant protein triggers tuberculin shock in infected guinea pigs.

Authors:  Stephen T Reece; Nicole Stride; Pamela Ovendale; Steven G Reed; Antonio Campos-Neto
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis.

Authors:  I Kramnik; W F Dietrich; P Demant; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 4.  Vaccines for tuberculosis: novel concepts and recent progress.

Authors:  T Mark Doherty; Peter Andersen
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

5.  Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology.

Authors:  V P Mohan; C A Scanga; K Yu; H M Scott; K E Tanaka; E Tsang; M M Tsai; J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Mycobacterial antigens induce apoptosis in human purified protein derivative-specific alphabeta T lymphocytes in a concentration-dependent manner.

Authors:  Afsaneh Soruri; Stefan Schweyer; Heinz-Joachim Radzun; Afshin Fayyazi
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

7.  Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.

Authors:  Mark Hatherill; Hendrik Geldenhuys; Bernadette Pienaar; Sara Suliman; Phalkun Chheng; Sara M Debanne; Daniel F Hoft; W Henry Boom; Willem A Hanekom; John L Johnson
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

Review 8.  Current and novel approaches to vaccine development against tuberculosis.

Authors:  Mark J Cayabyab; Lilia Macovei; Antonio Campos-Neto
Journal:  Front Cell Infect Microbiol       Date:  2012-12-06       Impact factor: 5.293

9.  Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosis.

Authors:  Cristina Vilaplana; Olga Gil; Neus Cáceres; Sergio Pinto; Jorge Díaz; Pere-Joan Cardona
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

10.  Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology.

Authors:  S Ehlers; J Benini; H D Held; C Roeck; G Alber; S Uhlig
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.